5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyPrimary Membranous NephropathyRecruitingPhase 22026-10-08NCT07096843
A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)Systemic Lupus ErthematosusRecruitingPhase 1 / Phase 22026-08-06NCT07564596
A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, autoimmune thrombocytopenic purpura, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyRecruitingPhase 1 / Phase 22026-03-27NCT07043946
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingPhase 12026-03-27NCT07011043
A Phase 1 Study of CLYM116 in Normal Healthy VolunteersFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorderRecruitingPhase 12026-02-20NCT07248865